Latest S-1 registration statements

NASDAQ
Iron Horse Acquisition II Corp. filed an exhibit-only amendment to its S-1 registration statement, detailing offering expenses, indemnification, and prior unregistered securities sales.
Global Interactive Technologies, Inc. is offering up to 3.8 million shares and warrants in a 'reasonable best efforts' offering to raise capital, facing substantial doubt about its ability to continue as a going concern.
NYSE
Selling stockholders of Miami International Holdings, Inc. are offering up to 6.75 million common shares, with the company receiving no proceeds from the sale.
NASDAQ
Galaxy Digital Inc. reported a significant increase in net income for Q3 2025, driven by gains in digital assets and investments, alongside major expansions in its AI/HPC data center business.
NASDAQ
Solidion Technology, an advanced battery company, filed an S-1/A registration statement for the resale of up to 7,076,660 shares of common stock by existing securityholders, with no direct cash proceeds to the company from these sales.
NASDAQ
Tempest Therapeutics, a clinical-stage biotechnology company, filed an S-1 registration statement for the resale of 1,172,414 common shares by a selling stockholder, issuable upon warrant exercise.
NASDAQ
Banzai International, Inc. filed an S-1 registration statement for the resale of up to 2,076,842 shares of Class A Common Stock, while reporting a significant increase in Q3 2025 revenue driven by recent acquisitions, but also continued substantial operating losses and a 'going concern' warning.
OQB
BrooQLy Inc., now operating as Dynamic Aerospace Systems, details its strategic shift to UAV manufacturing and logistics, recent acquisitions, and plans to raise up to $15 million, despite ongoing losses and going concern doubts.
NASDAQ
Selling stockholders offer 7 million Class A shares as Legence Corp. reports strong revenue growth and a major acquisition, but also increased net losses and internal control weaknesses.
NASDAQ
K2 Capital Acquisition Corporation, a newly formed SPAC, filed an amended S-1 registration statement for a $100 million initial public offering to target businesses in humanoid robotics, physical AI, and small modular nuclear reactors.
NASDAQ
Bimergen Energy Corporation files S-1/A for a public offering of 1.32M shares and pre-funded warrants to fund its utility-scale BESS and solar project development, targeting a NYSE listing.
NASDAQ
FreeCast, Inc. is preparing for a direct listing on the Nasdaq Global Market, registering 19.78 million Class A common shares for resale, while reporting reduced net losses and significant ad revenue growth, but faces ongoing 'going concern' doubts and a shareholder lawsuit.
NASDAQ
Terra Innovatum Global N.V., a micro modular nuclear solutions company, has successfully completed its business combination with GSR III Acquisition Corp. and commenced trading on Nasdaq under the symbol NKLR.
NASDAQ
Daedalus Special Acquisition Corp. filed a Rule 462(b) registration statement to offer an additional 2,875,000 units, each comprising one Class A ordinary share and one-fourth of a redeemable warrant.
NASDAQ
Focus Universal Inc. files an S-1 registration statement for the resale of up to 10,558,975 shares of common stock by selling stockholders, following a $7 million Series B Preferred Stock private placement.
OTC.Pink
APPlife Digital Solutions, an aftermarket auto parts e-commerce firm, filed an S-1 registration statement to register shares for resale and to facilitate a $15 million equity purchase agreement with C/M Capital Master Fund LP, amidst ongoing financial challenges and a going concern warning.
OQB
Polomar Health Services, Inc. filed an amendment to its S-1 registration statement, detailing offering expenses, indemnification policies, and recent unregistered stock issuances.
OID
Charging Robotics Inc. filed an S-1/A registration statement for the resale of up to 7,928,852 shares of common stock by selling stockholders, contingent on its planned uplisting to the Nasdaq Capital Market.
Guident Corp. filed an S-1/A registration statement for an underwritten public offering of 1,704,545 shares of common stock, aiming for a Nasdaq listing and an estimated price range of $7.80 to $9.80 per share.
OTC.Pink
First Choice Healthcare Solutions is undergoing a strategic transformation, shifting from orthopedic services to a national network of primary care and wellness clinics, supported by a $12 million public offering.
NYSE
Andersen Group Inc. files for an initial public offering of 11 million Class A common shares at $14-$16, revealing a complex UP-C structure and significant obligations to existing owners.
NASDAQ
Silicon Valley Acquisition Corp., a newly formed SPAC, filed an amended registration statement for its $200 million initial public offering, targeting high-growth sectors like fintech, AI, and energy transition.
NASDAQ
GRI Bio, Inc. announces a new public offering of common stock and warrants to raise up to $10 million, alongside positive topline Phase 2a clinical trial results for its lead IPF candidate, GRI-0621, despite ongoing financial challenges and Nasdaq non-compliance.
NASDAQ
Ethos Technologies Inc., a digital life insurance platform, has filed an S-1/A registration statement for its initial public offering, highlighting significant revenue growth and recent GAAP profitability.
Klotho Neurosciences, Inc. filed an S-1 registration statement for the resale of up to 35 million shares of common stock by existing selling stockholders, including shares convertible from Series C Preferred Stock.
NASDAQ
Biofrontera Inc. files an S-1 registration statement for the resale of 4,000,640 common shares by selling stockholders, with no proceeds going to the company.
OQB
Polomar Health Services, a compounding pharmacy, reported significant losses and negative working capital as it transitions its business model and pursues a merger with Altanine Inc., which is expected to give Altanine shareholders 80% ownership of the combined entity.
Inspire Veterinary Partners reports reduced net losses and improved cash flow from operations, but faces imminent Nasdaq delisting and ongoing 'going concern' doubts.
OQB
CERO Therapeutics Holdings, Inc. filed an S-1 registration statement for the resale of up to 729.6 million common shares by Keystone Capital Partners, LLC, following its delisting from Nasdaq to OTCQB.
OQB
Mitesco, Inc. is undergoing a significant business model transformation, pivoting from unprofitable medical clinics to data center services and AI software development, while grappling with substantial debt and a going concern warning.